TriMas
TRSNASDAQUSD
- Source valuation snapshot. Not a live recalculation.
- Latest filed annual earnings; price snapshot date unavailable. Not forward P/E.
- Diluted earnings per share from the latest filed annual.
- $37.86 Prior regular-session close from the quote source.
- $37.61–$38.17 Regular-session low and high so far today.
- 454.3K Regular-session shares traded · Nov 11, 4:00 PM ET.
- Feb 25 projected Projected for 2027-02-25 from the company’s own results filings (SEC 8-K Item 2.02). The company has not confirmed the date.
- $30.43–$45.43 52-week trading low and high returned by the quote source.
Understand the Business
Why the Stock Moved
Period-matched expectations history is not yet available. Current metrics are not a substitute for a historical explanation.
The core investment thesis
Own TRS if its engineered packaging, aerospace and specialty products remain specified-in enough to restore margins and cash, but the stock should not be underwritten off the FY2025 EPS spike alone.
TRS price history
Loading recent earnings…
Investment thesis
What must happen next
TriMas’s products remain specified-in enough with consumer, aerospace/defense and industrial customers that buyers keep sourcing from TriMas rather than switching to lower-cost alternatives.HoldingMateriality: High
FY2025 annual GAAP revenue was $645.72 million, up from FY2024 annual GAAP revenue of $630.80 million. If this holds, revenue stability gives the company a base for margin recovery; if it breaks, fixed-cost absorption and pricing power deteriorate before reported earnings do.
Watch: Packaging customers shift dispensing or closure programs to AptarGroup, Berry Global or Silgan on price or service.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 annual GAAP revenue was $645.72 million, up from FY2024 annual GAAP revenue of $630.80 million.
Open source ↗TriMas’s engineered products and manufacturing know-how must recover value-added economics, meaning price, mix and productivity offset raw-material, labor and freight pressure.HoldingMateriality: High
FY2025 annual GAAP gross_profit was $138.16 million, up from FY2024 annual GAAP gross_profit of $129.54 million. Margin recovery is the difference between a niche industrial platform and a commodity manufacturer with limited pricing power.
Watch: Resin, metal, labor or freight inflation accelerates faster than contract pass-through mechanisms allow.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 annual GAAP gross_profit was $138.16 million, up from FY2024 annual GAAP gross_profit of $129.54 million.
Open source ↗Plant utilization, cost actions and portfolio discipline must convert a stable sales base into operating leverage rather than recurring restructuring and under-absorption.HoldingMateriality: Medium
FY2025 annual GAAP operating_income was $41.30 million, up from FY2024 annual GAAP operating_income of $15.17 million. If operating leverage is real, incremental revenue and mix improvement should compound into higher earnings; if not, the business remains vulnerable to modest demand swings.
Watch: Persistent underutilization at manufacturing facilities prevents fixed costs from being absorbed even if revenue is stable.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 annual GAAP operating_income was $41.30 million, up from FY2024 annual GAAP operating_income of $15.17 million.
Open source ↗Working-capital discipline and customer-payment terms must let TriMas convert industrial earnings into cash that funds reinvestment and balance-sheet repair.StrengtheningMateriality: Medium
FY2025 annual GAAP operating_cash_flow was $117.45 million, up from FY2024 annual GAAP operating_cash_flow of $63.78 million. Cash conversion determines whether the turnaround creates owner value or is consumed by inventory, receivables and capital needs.
Watch: Inventory builds ahead of aerospace or packaging programs fail to convert into shipments.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 annual GAAP operating_cash_flow was $117.45 million, up from FY2024 annual GAAP operating_cash_flow of $63.78 million.
Open source ↗Capital allocation must avoid letting acquisitions, restructuring or leverage consume the cash generated by the operating businesses.HoldingMateriality: Medium
FY2025 liabilities were $779.49 million versus FY2025 assets of $1.48508 billion and equity of $705.59 million, so the provided balance sheet does not show negative equity. A margin recovery helps shareholders only if the balance sheet does not claim the upside through higher interest burden, refinancing risk or dilution.
Watch: Debt-funded acquisitions are made at high multiples without clear segment-level margin improvement.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 liabilities were $779.49 million versus FY2025 assets of $1.48508 billion and equity of $705.59 million, so the provided balance.
Open source ↗Future per-share value must be supported by recurring operating profit, not one-time gains or non-operating items; FY2025 GAAP EPS is not a sufficient proof point by itself.WeakeningMateriality: Medium
FY2025 annual GAAP eps_diluted was $2.95, up sharply from FY2024 annual GAAP eps_diluted of $0.60. If EPS is not backed by recurring operations, investors risk capitalizing a temporary accounting outcome instead of a durable earnings base.
Watch: Future filings show the FY2025 EPS uplift came from asset-sale gains, tax items or discontinued operations rather than continuing operating earnings.
Supporting sources
Source notes are factual paraphrases; read the original disclosures below.
FY2025 annual GAAP eps_diluted was $2.95, up sharply from FY2024 annual GAAP eps_diluted of $0.60.
Open source ↗
Full investment case & evidence
Loading the original research archive…
Original research
TriMas’s products remain specified-in enough with consumer, aerospace/defense and industrial customers that buyers keep sourcing from TriMas rather than switching to lower-cost alternatives. If this holds, revenue stability gives the company a base for margin recovery; if it breaks, fixed-cost absorption and pricing power deteriorate before reported earnings do.
TriMas’s engineered products and manufacturing know-how must recover value-added economics, meaning price, mix and productivity offset raw-material, labor and freight pressure. Margin recovery is the difference between a niche industrial platform and a commodity manufacturer with limited pricing power.
Plant utilization, cost actions and portfolio discipline must convert a stable sales base into operating leverage rather than recurring restructuring and under-absorption. If operating leverage is real, incremental revenue and mix improvement should compound into higher earnings; if not, the business remains vulnerable to modest demand swings.
Working-capital discipline and customer-payment terms must let TriMas convert industrial earnings into cash that funds reinvestment and balance-sheet repair. Cash conversion determines whether the turnaround creates owner value or is consumed by inventory, receivables and capital needs.
Capital allocation must avoid letting acquisitions, restructuring or leverage consume the cash generated by the operating businesses. A margin recovery helps shareholders only if the balance sheet does not claim the upside through higher interest burden, refinancing risk or dilution.
Future per-share value must be supported by recurring operating profit, not one-time gains or non-operating items; FY2025 GAAP EPS is not a sufficient proof point by itself. If EPS is not backed by recurring operations, investors risk capitalizing a temporary accounting outcome instead of a durable earnings base.
All standing thesis claims
Original report summary
its engineered packaging, aerospace and specialty products remain specified-in enough to restore margins and cash, but the stock should not be underwritten off the FY2025 EPS spike alone.
Bull case and bear case
Bull case and bear case for Trimas
Where the evidence on Trimas disagrees: Mixed on the latest evidence (Oct 16, 2026). Of its 6 thesis points, 1 strengthening, 4 holding and 1 weakening.
Bull case: what the evidence supports
TriMas’s products remain specified-in enough with consumer, aerospace/defense and industrial customers that buyers keep sourcing from TriMas rather than switching to lower-cost alternatives.
TriMas’s engineered products and manufacturing know-how must recover value-added economics, meaning price, mix and productivity offset raw-material, labor and freight pressure.
Plant utilization, cost actions and portfolio discipline must convert a stable sales base into operating leverage rather than recurring restructuring and under-absorption.
Working-capital discipline and customer-payment terms must let TriMas convert industrial earnings into cash that funds reinvestment and balance-sheet repair.
Capital allocation must avoid letting acquisitions, restructuring or leverage consume the cash generated by the operating businesses.
Bear case: what the evidence questions
Future per-share value must be supported by recurring operating profit, not one-time gains or non-operating items; FY2025 GAAP EPS is not a sufficient proof point by itself.
Thesis-Break Engine
What has broken in Trimas’s thesis
Each break OptimistFi flagged on Trimas, dated — with what has historically followed the same kind of break across the market, not a forecast for Trimas.
- Late SEC filingcondition set before this filing
Across all companies, this kind of break has happened 4,811 times before. Those stocks trailed comparable companies by a median of 12% over the next six months, and 52% of them trailed it by 10 points or more.
MARKET + FINANCIAL SNAPSHOT
The numbers behind the thesis
What Changed
- MixedReported results of operations (earnings release).
Trimas filed an SEC 8-K on 2026-07-30: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
- MixedReported results of operations (earnings release).
Trimas filed an SEC 8-K on 2026-04-30: Reported results of operations (earnings release). It is a dated development that tests the current thesis.
Risks / falsifiers
What could break the thesis
- Packaging customers shift dispensing or closure programs to AptarGroup, Berry Global or Silgan on price or service.
- Resin, metal, labor or freight inflation accelerates faster than contract pass-through mechanisms allow.
- Persistent underutilization at manufacturing facilities prevents fixed costs from being absorbed even if revenue is stable.
- Inventory builds ahead of aerospace or packaging programs fail to convert into shipments.
- Debt-funded acquisitions are made at high multiples without clear segment-level margin improvement.
- Future filings show the FY2025 EPS uplift came from asset-sale gains, tax items or discontinued operations rather than continuing operating earnings.
TRS news
Loading headlines…
Financial statements
TRS income statement
Annual filed results · USD · Oldest to newest. Margins are calculated from the reported figures.
TRS: quick answers
- When does Trimas (TRS) report earnings next?
- Trimas's next results are projected for February 25, 2027, from the dates of its own results filings with the SEC. The company has not confirmed the date. It last reported on October 29, 2026. Earnings calendar
- What is TRS's short interest?
- As of October 30, 2026, 3.5M TRS shares were sold short, 9.71% of its shares outstanding, up 3.6% from the count before. At the stock's average daily volume that is 8.3 days to cover. FINRA publishes the count twice a month. TRS short interest history
- Have members of Congress traded TRS?
- 18 trades in TRS have been disclosed under the STOCK Act by members of Congress, the President or senior officials, none in reports made public in the last 90 days. Every disclosed TRS trade